NCT00048750View on ClinicalTrials.gov

Comparative Study of Micafungin (FK463) Versus Placebo as Prophylactic Antifungal Therapy in the ICU

PHASE3TerminatedINTERVENTIONAL
Enrollment

104

Participants

Timeline

Start Date

January 31, 2003

Primary Completion Date

June 30, 2003

Study Completion Date

June 30, 2003

Conditions
Invasive Fungal Infections
Interventions
DRUG

Micafungin

IV

DRUG

Placebo

IV

Trial Locations (48)

14642

Rochester

15213

Pittsburgh

17033

Hershey

19104

Philadelphia

20010

Washington D.C.

21201

Baltimore

21287

Baltimore

22906

Charlottesville

27110

Durham

27710

Durham

30303

Atlanta

33601

Tampa

35294

Birmingham

37212

Nashville

45267

Cincinnati

46202

Indianapolis

46260

Indianapolis

46390

Indianapolis

48201

Detroit

55455

Minneapolis

60153

Maywood

63110

St Louis

68198

Omaha

72205

Little Rock

75246

Dallas

78229

San Antonio

80262

Denver

84132

Salt Lake City

90033

Los Angeles

90048

Los Angeles

92868

Orange

93102

Santa Barbara

94110

San Francisco

94304

Stanford

94305

Stanford

94609

Oakland

95817

Sacramento

98104

Seattle

04102

Portland

02114

Boston

07103

Newark

L8V 1C3

Hamilton

N6A 5A5

London

K1H 8L6

Ottawa

J4V 2H1

Greenfield Park

H3A 1A1

Montreal

S4P 0W5

Regina

S7N0W8

Saskatoon

Sponsors
All Listed Sponsors
lead

Astellas Pharma Inc

INDUSTRY